[1] Harris E N, Weigel P H. The ligand-binding profile of HARE:hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E[J]. Glycobiology, 2008, 18(8):638-648.doi:10.1093/glycob/cwn045. [2] Tamura Y, Adachi H, Osuga J, Ohashi K, Yahagi N, Sekiya M, Okazaki H, Tomita S, Iizuka Y, Shimano H, Nagai R, Kimura S, Tsujimoto M, Ishibashi S. FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products[J]. Journal of Biological Chemistry, 2003, 278(15):12613-12617. doi:10.1074/jbc.M210211200. [3] D'souza S,Park S Y,Kim I S.Stabilin-2 acts as an engulfment receptor for the phosphatidylserine-dependent clearance of primary necrotic cells[J].Biochemical and Biophysical Research Communications, 2013, 432(3):412-417. doi:10.1016/j.bbrc.2013.01.133. [4] Adachi H, Tsujimoto M. FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities[J]. Journal of Biological Chemistry, 2002, 277(37):34264-34270. doi:10.1074/jbc.M204277200. [5] Jung M Y, Park S Y, Kim I S.Stabilin-2 is involved in lymphocyte adhesion to the hepatic sinusoidal endothelium via the interaction with alphaMbeta2 integrin[J]. Journal of Leukocyte Biology, 2007, 82(5):1156-1165. doi:10.1189/jlb.0107052. [6] Park S Y, Jung M Y, Kim H J, Lee S J, Kim S Y, Lee B H, Kwon T H, Park R W, Kim I S. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor[J]. Cell Death and Differentiation, 2008, 15(1):192-201. doi:10.1038/sj.cdd.4402242. [7] Han M W, Lee J C, Park S Y, Kim Y M, Cho K J, Kim S W, Lee M, Nam S Y, Kim I S, Kim S Y. Homotypic interaction of Stabilin-2 plays a critical role in lymph node metastasis of tongue cancer[J]. Anticancer Research,2016, 36(12):6611-6618. doi:10.21873/anticanres.11267. [8] Géraud C, Mogler C, Runge A, Evdokimov K, Lu S, Schledzewski K, Arnold B, Hämmerling G, Koch P S, Breuhahn K, Longerich T, Marx A, Weiss C, Damm F, Schmieder A, Schirmacher P, Augustin H G, Goerdt S. Endothelial transdifferentiation in hepatocellular carcinoma:loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival[J]. Liver International, 2013, 33(9):1428-1440. doi:10.1111/liv.12262. [9] Park S Y, Yun Y, Lim J S, Kim M J, Kim S Y, Kim J E, Kim I S. Stabilin-2 modulates the efficiencyof myoblast fusion during myogenic differentiation and muscle regeneration[J]. Nature Communications,2016, 7:10871. doi:10.1038/ncomms10871. [10] Hamoud N, Tran V, Aimi T, Kakegawa W, Lahaie S, Thibault M P, Pelletier A, Wong G W, Kim I S, Kania A, Yuzaki M, Bouvier M, Côté J F. Spatiotemporal regulation of the GPCR activity of BAI3 by C1qL4 and Stabilin-2 controls myoblast fusion[J]. Nature Communication, 2018, 9(1):4470. doi:10.1038/s41467-018-06897-5. [11] 龙熙, 柴捷, 赵久刚, 蓝静, 郭宗义, 张廷焕. 猪EIF2S3 基因启动子的克隆、活性及转录调控元件分析[J]. 华北农学报, 2018, 33(S1):38-44. doi:10.7668/hbnxb.2018.S1.007. Lng X,Chai J,Zhao J G,Lan J,Guo Z Y,Zhang T H.Cloning,transcriptional activity and regulatory elements analysis of porcine EIF2S3 gene promoter[J]. Acta Agriculturae Boreali-sinica, 2018, 33(S1):38-44. [12] Attwood J T, Yung R L, Richardson B C. DNA methylation and the regulation of genetranscription[J]. Cellular and Molecular Life Sciences, 2002, 59(2):241-257. doi:10.1007/s00018-002-8420-z. [13] Banovich N E, Lan X, McVicker G, van de Geijn B, Degner J F, Blischak J D, Roux J, Pritchard J K, Gilad Y. Methylation QTLs are associated with coordinated changes in transcription factor binding, histone modifications, and gene expression levels[J]. Plos Genetics, 2014,10(9):e1004663. doi:10.1371/journal.pgen.1004663. [14] Savage K I, Harkin D P.BRCA,a ‘complex’ protein involved in the maintenance of genomic stability[J]. Febs Journal, 2015, 282(4):630-646. doi:10.1111/febs.13150. [15] Poole L A, Cortez D. Functions of SMARCAL1, ZRANB3, and HLTF in maintaining genome stability[J]. Critical Reviews in Biochemistry and Molecular Biology, 2017, 52(6):696-714. doi:10.1080/10409238.2017.1380597. [16] Segre, J A, Bauer C, Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin[J]. Nature Genetics, 1999, 22(4):356-360. doi:10.1038/11926. [17] Liu Y, Wen J K, Dong L H, Zheng B, Han M. Krüppel-like factor (KLF) 5 mediates cyclin D1expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs[J]. Acta Pharmacologica Sinica, 2010, 31(1):10-18. doi:10.1038/aps.2009.185. [18] Rane M J, Zhao Y G, Cai L. Krupsilonppel-like factors (KLFs) in renal physiology and disease[J]. EbioMedicine, 2019, 40:743-750. doi:10.1016/j.ebiom.2019.01.021. [19] Walters R D, Drullinger L F, Kugel J F, Goodrich J A. NFATc2 recruits cJun homodimers to an NFAT site to synergistically activate interleukin-2 transcription[J]. Molecular Immunology, 2013,56(1-2):48-56. doi:10.1016/j.molimm.2013.03.022. [20] Becker M, Heib V, Klein M, Doener F, Bopp T, Taube C, Radsak M, Schild H, Schmitt E, Stassen M. Impaired mast cell-driven immune responses in mice lacking the transcription factor NFATc2[J].The Journal of Immunology, 2009, 182(10):6136-6142. doi:10.4049/jimmunol.0802878. [21] Fei Q, Lin J S, Meng H, Wang B Q, Yang Y, Wang Q, Su N, Li J J, Li D. Identification of upstream regulators for synovial expression signature genes in osteoarthritis[J]. Joint Bone Spine, 2016,83(5):545-551. doi:10.1016/j.jbspin.2015.09.001. [22] Gao L, Sun C, Qiu H L, Liu H, Shao H J, Wang J, Li W X. Cloning and characterization of a novel human zinc finger gene, hKid3, from a C2H2-ZNF enriched human embryonic cDNA library[J]. Biochemical and Biophysical Research Communications, 2004, 325(4):1145-1152. doi:10.1016/j.bbrc.2004.10.158. |